Illustrator and podcaster Andy J. Pizza shares the routines and practices that help to direct his creativity.

“After being so low for so long, I’m just happy to be alive.”

A study conducted by researchers from Hamamatsu University School of Medicine, in collaboration with several international institutions, has unveiled a critical link between melatonin secretion and the severity of ADHD (attention deficit hyperactivity disorder) symptoms in children. The findings, published in Psychiatry Research Communications, suggest that genetic variations affecting melatonin production may play a significant role in the…

Join Tim Wilens, MD, co-director of the Center for Addiction Medicine at Massachusetts General Hospital and a professor of psychiatry at Harvard Medical School, as he discusses innovative, multidisciplinary approaches for managing ADHD beyond traditional medications.

Children born in July and August are at least 40% more likely to be diagnosed with—and to receive prescriptions for—attention deficit hyperactivity disorder (ADHD), than children born in September and October, new research has found. This research is being presented at the European Association of Labour Economics on September 7 and is published as a…

A study conducted in Hungary found that adolescents with a smaller volume in the amygdala region of the brain have a higher risk of attention-deficit/hyperactivity disorder (ADHD). They also tend to experience more severe symptoms of this disorder. The research was published in Research on Child and Adolescent Psychopathology.

ABC News’ Diane Macedo discusses why there is a rising number of women being diagnosed with ADHD later in life.

A new study reveals nuanced findings on the neuropsychiatric risks of prenatal cannabis exposure. The research found a slight increase in the risk of ADHD and a heightened vulnerability to cannabis use in offspring. These results highlight the need for continued caution and further investigation into the long-term effects of cannabis use during pregnancy.

Sept 4 (Reuters) – The U.S. Drug Enforcement Administration (DEA) has increased the production limit for Takeda Pharmaceutical’s (4502.T), opens new tab ADHD drug Vyvanse and its generic versions by about 24% to address the medicine’s ongoing shortage in the United States. The raised production limit follows the Food and Drug Administration’s request in July,…

Does your child have ADHD or do they have vision problems? A neuro-optometrist explains why it’s good not to rule out vision therapy.

HENRY COUNTY, Ky. — A little girl remains in the intensive care unit after receiving a potentially bad batch of medication. Henry County EMS said prescriptions filled at Med Save Pharmacy in Eminence for clonidine oral suspension sent three patients to the hospital.

ARKANSAS, USA — Pharmacies in Northwest Arkansas and the River Valley continue to feel the effects of a nationwide shortage of the drugs used to treat ADHD (Attention deficit hyperactivity disorder). The shortage has been ongoing since 2022.